July 24, 2013in Access to Medicines, Blogs, Canada, European Union, IP, Patents, Pharmaceutical Drugs, Regulatory Policy, Uncategorized, US, US-Canada Relations0by Editor1506 Time for a Change? Fraser Institute Urges Canada to Strengthen its Pharmaceutical IP Laws A little over a week ago, the Fraser Institute, a prominent and independent Canadian public policy think tank, released a report calling for a strengthening of intellectual property protection for…
